Las Vegas, NV -- (SBWIRE) -- 01/08/2014 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Affymetrix, Inc.(NASDAQ:AFFX), RF Micro Devices, Inc.(NASDAQ:RFMD), Frontline Ltd.(NYSE:FRO), Epizyme Inc(NASDAQ:EPZM)
Affymetrix, Inc.(NASDAQ:AFFX) was a volume gainer of 3.90 million shares and the average volume of the stock remained 774,435.00 shares. The stock opened the session at $8.49 and finished at the end of the day at $8.81 and the stock escalated 11.52%.The market capitalization of the stock remained 633.59 million. Affymetrix, Inc. (Affymetrix) is engaged in the development, manufacture, sale and service of consumables and systems for genetic analysis in the life sciences and clinical healthcare markets. Affymetrix has developed its GeneChip system and related microarray technology as a platform for acquiring, analyzing and managing genetic information.
For How Long AFFX will fight for Profitability? Read This Trend Analysis report
In the preceding trading session, RF Micro Devices, Inc.(NASDAQ:RFMD) exchanged 3.89 million shares and the average volume remained 4.04 million shares. The stock closed the session at $4.84 with the drop of -0.10%. RF Micro Devices, Inc. is engaged in the design and manufacture of radio frequency (RF) solutions. The Company offers products that range from single-function components to integrated circuits and multi-chip modules (MCMs). During the fiscal year ended March 30, 2013 (fiscal 2013), its foundry services were realigned from its Compound Semiconductor Group to its MPG.
Why Should Investors Buy RFMD After the Recent Fall? Just Go Here and Find Out
Frontline Ltd.(NYSE:FRO) enhanced 5.31% and its closing price was $4.36. The volume of the stock was 3.86 million shares and the average volume remained 1.83 million shares. The market capitalization of the stock remained 343.76 million. The beta of the stock remained 2.05. Frontline Ltd. is a Bermuda-based shipping company engaged primarily in the ownership and operation of oil tanker. The Company operates oil tankers of two sizes: Very Large Crude Carriers (VLCCs), which are between 200,000 and 320,000 deadweight tonnages (dwt), and Suezmax tankers, which are vessels between 120,000 and 170,000 dwt.
Why Should Investors Buy FRO After The Recent Gain? Just Go Here and Find Out
Epizyme Inc(NASDAQ:EPZM) exchanged 3.81 million shares in the previous trading session, and its average trading remained 223,637.00 shares. EPZM advanced 75.56% and it closed the trading at $35.99. The market capitalization of the stock remained 1.02 million. Epizyme, Inc. is a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize personalized therapeutics for patients with genetically defined cancers. The Company has identified its two lead product candidates using its product platform.
For How Long EPZM’s Gloss will Attract Investors? Find out via this report
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)